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TrophoblastThe placenta is composed of multiple trophoblast cell types that have diverse endocrine, vascular and nutrient
transport functions. We have developed a transgenic system to investigate the developmental and functional
roles of speciﬁc cell types using conditional expression of a cytotoxin to induce cell ablation in transgenic
mice. The Tpbpa gene is expressed in ectoplacental cone cells starting between embryonic days (E) 7.5 and 8.5,
and later in the spongiotrophoblast layer of the mature placenta. Tpbpa-positive cells are progenitors of many
trophoblast subtypes including three subtypes of trophoblast giant cells (TGCs) and glycogen trophoblast
cells. We used a Cre recombinase transgene driven by the Tpbpa promoter to irreversibly activate a diphtheria
toxin A (DTA) transgene. Cre/DTA double transgenic placentas showed dramatic reduction of Tpbpa-positive
spongiotrophoblast cells by E10.5 and conceptuses died by ~E11.5. The number of cells associated with
maternal blood spaces, spiral artery TGCs (SpA-TGCs) and canal TGCs, and glycogen trophoblast cells were
reduced. The loss of these speciﬁc trophoblast subtypes, especially SpA-TGCs, was correlatedwith a decrease in
maternal spiral artery diameters, indicating a critical role of these cells inmodulating thematernal vasculature.
In contrast, parietal TGCs were not signiﬁcantly reduced by progenitor cell ablation, suggesting that there is
compensatory growth of this population and indeed a population of Ascl2 (Mash2)-positive/Tpbpa-negative
cells was increased in the spongiotrophoblast layer in the Cre/DTA double transgenics. Ourwork demonstrates
that the Tpbpa-positive lineage is essential for placental function and particularly critical for maternal
vasculature remodeling.l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
A key process during pregnancy is that the feto-placental unit builds
an intimate relationship with the mother through alteration of the
uterine environment and facilitation of maternal blood through the
placenta (Cross et al., 2002). At the feto-maternal interface, maternal
blood ﬂow through the placenta increases dramatically due to not
only blood vessel growth into the implantation site after uterine
decidualization (angiogenesis), but also a signiﬁcant vasodilation that
results in increased blood ﬂow (Cross et al., 2002). These processes are
thought to be regulated by the interactions of various trophoblast cell
subtypes in the fetal placenta with maternal endothelial cells and
immune cells. However, the deﬁnitive function of speciﬁc trophoblast
cell subtypes has not been well studied due to the lack of appropriate
models. Mouse trophoblast giant cells (TGCs) and glycogen trophoblast
cells are analogous to invading extravillous cytotrophoblast cells of
the human placenta and invade the utero-placental spiral arteries or
interstitially into the decidua, respectively, and are associated with theremodeling of the spiral arteries into dilated, inelastic tubes without
maternal vasomotor control. Disturbed remodeling in humans leads to
increased utero-placental vascular resistance and is commonly found
associated with intrauterine growth restriction and preeclampsia
(Kaufmann et al., 2003; Lyall and Belfort, 2007). Thus, understanding
the role of speciﬁc trophoblast cells subtypes will provide us insights
into human placenta pathologies and diseases of pregnancy.
TGCs are thought to be critical for embryo implantation, establish-
ment of the feto-maternal interface and maternal adaptations to
pregnancy based on their obvious invasive and endocrine properties.
Four TGC subtypes have been reported within the mature placenta:
parietal TGCs that line the implantation site (P-TGCs), those found
invading the maternal spiral arteries (SpA-TGCs), TGCs within the
maternal blood canals (C-TGCs) that connect the spiral arteries with
the labyrinth layer, and TGCs foundwithin the sinusoidal spaces of the
labyrinth (S-TGCs) (Simmons et al., 2007). Their distinct locations and
expression of prolactin-like protein hormones (Simmons et al., 2008)
suggest that they play distinct roles at the feto-maternal interface.
Cells within the ectoplacental cone and later the spongiotrophoblast
layer are recognized as being progenitors of TGCs and express the
spongiotrophoblast-speciﬁc gene 4311/Tpbpa (Carney et al., 1993;
Lescisin et al., 1988). The lineage relationship between Tpbpa-positive
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lineage tracing in which Tpbpa-Cre transgenic mice were crossed
with mice carrying a Cre recombinase-activated reporter gene. Tpbpa-
positive cells were found to give rise to all SpA-TGCs, aswell as ~50% of
C-TGCs and P-TGCs, but none of the S-TGCs (Simmons et al., 2007). To
investigate the function of cells that are derived from Tpbpa-positive
cells, and in particular SpA-TGCs, we crossed the Tpbpa-Cremice with
mice carrying a Cre-activated diphtheria toxin A (DTA) transgene. As a
result, we were able to speciﬁcally ablate the Tpbpa-positive lineage




Tpbpa-Cre transgenic mice (Simmons et al., 2007) were bred and
maintained on a C57BL6 background. Line 5 Tpbpa-Cre-GFP mice are
used for our studies since the temporal and spatial expression of GFP
in this line is similar to endogenous Tpbpa expression (Calzonetti
et al., 1995; Simmons et al., 2007). ROSA26-eGFP-DTA transgenic mice
(Ivanova et al., 2005) were obtained from the Jackson Laboratory (Bar
Harbor, ME, USA Strain Name: STOCK Gt(ROSA)26Sortm1(DTA)Jpmb/J
Stock Number: 006331). For cell ablation, ROSA26-eGFP-DTA homo-
zygous female mice (DTA/DTA) were crossed with Tpbpa-Cre male
mice. Of their progeny, half were DTA/+;Tpbpa-Cre double transgenic
that undergo Cre-activated cell ablation and half are single transgenic
mice (DTA/+). All animal procedures in this study were carried
out in accordance with the guidelines of the Canadian Council on
Animal Care and the University of Calgary Animal Welfare Committee
(Protocol No. M06045).
Genotyping
Genotypes of the embryos and adult animals were determined by
polymerase chain reaction (PCR). Genomic DNA was isolated from
yolk sac or ear notches of embryos or adult mice. Primers (transgenic
primer: 5′-gcg aag agt ttg tcc tca acc-3′, common primer: 5′-aaa gtc
gct ctg agt tgt tat-3′, wild type reverse primer: 5′-gga ggg gga gaa atg
gat atg-3′) were used for detecting DTA transgenic and wildtype
alleles. Primers (forward primer: 5′-tcc agt gac agt ctt gat cct taa t-3′,
reverse primer: 5′-aaa ttt tgg tgt acg gtc agt aaa t-3′) were used for
detecting the Tpbpa-Cre transgene.
Tissue preparation, H&E staining and immunohistochemistry
Placentas and embryos were dissected and harvested from timed
matings (E9.5, 10.5, 11.5 and 12.5) and ﬁxed overnight in 4%
paraformaldehyde in phosphate-buffered saline (PBS). Tissues were
then rinsed in PBS for three times. For parafﬁn embedding, tissues
were dehydrated through a graded ethanol series and embedded in
parafﬁn wax. Parafﬁn blocks were stored and cut at room tempera-
ture. For frozen histological sections, tissues were incubated in 10%
and 25% sucrose in PBS for 2 overnights, embedded in OCT at 4 °C for
2 h, and frozen in ethanol bath with dry ice. OCT blocks were then
stored at−70 °C and cut at−20 °C. Histological sectionswere stained
with Hematoxylin (Sigma Gill No.2 GHS232) and Eosin.
To investigate the localization and expression pattern of perforin
in the implantation sites, the hydrated parafﬁn sections were
incubated with 1:200 rat anti-mouse perforin monoclonal antibody
(Abcam Ab16074) overnight at 4 °C after heat-mediated antigen
retrieval. Detection of the primary antibody was carried out using
a peroxidase-conjugated donkey anti-rat IgG (H+L) secondary
antibody 1:300 (Jackson ImmunoResearch, 712-035-150). After the
detection of peroxidase activity using diaminobenzidine (DAB), the
sections were brieﬂy counterstained with hematoxylin and mounted.Interferon-γ expression was detected on the acetone-ﬁxed frozen
sections using 1:200 rabbit an anti-mouse interferon-γ polyclonal
antibody (Abbiotec 250708).
RNA in situ hybridization on tissue sections
RNA in situ hybridization on parafﬁn sections was carried out as
previously described (Simmons et al., 2007). Conceptuses were
dissected out of the uterus at E9.5, 10.5, 11.5 and 12.5 (E0.5 is deﬁned
as noon of the day on which vaginal plugging was detected). In situ
probes used included: Prl3d1/Pl1, Prl3b1/Pl2, Prl2c2/Plf, Prl4a1/Plpa,
Pcdh12, Pecam1, Tpbpa (Simmons et al., 2008) and Ascl2/Mash2 (Scott
et al., 2000). Digoxigenin-labeled probes were prepared by using
digoxigenin labeling mix (Boehringer Mannheim) and detected by
using an anti-digoxigenin–alkaline phosphatase conjugate (Boehringer
Mannheim).
For double in situ hybridization experiments, the same protocol
was carried out on cryo-sections with minor modiﬁcations. Detailed
procedures were described before (Simmons et al., 2007). Probes
labeled with ﬂuorescein as well as digoxigenin according to the
manufacturer's instructions and added to the hybridization mix. After
the digoxigenin probe was detected with NBT/BCIP, the enzyme was
inactivated with heating to 65 °C for 30 min in 1× MABT, followed by
30 min incubation in 0.1 M glycine pH2.2, blocked for 1 h in blocking
solution and incubated overnight at 4 °C with anti-ﬂuorescein
antibody (Roche, 1:2500). Fluorescein probes were detected by
incubation with INT/BCIP (Roche) until a brown precipitate formed.
Reactions were stopped in PBS, counterstained with nuclear fast red,
and mounted under 50% glycerol/PBS for microscopy.
Phospho-histone H3 immunohistochemistry following in situ hybridization
OCT embedded cryo-sections were processed initially as for
regular in situ hybridization. After the digoxigenin probewas detected
with NBT/BCIP, sections were washed in PBS and blocked with normal
donkey serum from the host species of the secondary antibody for 1 h.
Sections were incubated with anti-phospho-histone H3 (1:200;
Upstate 06-570) overnight at 4 °C and then incubated with 1:300
Donkey anti-rabbit HRP conjugated secondary antibody (NA934V, GE
healthcare) for 1 h. Each step was separated by careful washings in
PBS. Colorimetric staining was done with diaminobenzidine.
TUNEL
The DeadEnd Colorimetric TUNEL system was used to assess
apoptosis (Promega, G7130Madison, USA) according tomanufacturer's
instructions. Parafﬁn sections were de-parafﬁnized in fresh xylene,
rehydrated and incubated with 20 μg/ml of proteinase K for 15 min and
rinsed in PBS. The sections were incubated with equilibration buffer for
5–10 min and then with rTdT (Terminal Deoxynucleotidyl Transferase,
Recombinant) reaction mix including rTdT enzyme and biotinylated
nucleotide mix in a humidiﬁed atmosphere at 37 °C for 60 min. They
were subsequently washed by immersing the slides in 2× SSC for at
room temperature for 15 min. The endogenous peroxidase activity was
blockedwith 0.3%hydrogenperoxide. The sectionswere then incubated
with Streptavidin HRP for 30 min. Each step was separated by careful
washings in PBS. Staining was done with diaminobenzidine.
Quantitative analysis of P-TGCs, SpA-TGC lined spiral arteries, spiral
artery diameter and maternal blood space
For quantitative analysis of Prl3d1/Pl1-positive P-TGCs, 8 different
placentas each from E10.5 control (DTA/+) conceptuses and DTA/+;
Tpbpa-Cre conceptuses respectively were studied. Four sagittal, non-
adjacent sectionswith even distance apart at the center of the placenta
were stained with Prl3d1/Pl1 and used for measurement of Prl3d1/Pl1-
Table 1











E9.5 0 21 0 27 3 51
E10.5 0 21 6 21 2 50
E11.5 0 22 18 0 1 41
E12.5 0 16 26 0 4 46
a Very early resorption sites that the genotype cannot be determined.
233D. Hu, J.C. Cross / Developmental Biology 358 (2011) 231–239positive cell number per section and area. The ImageJmanual counting
and area measurement tool was used for the analysis.
For quantitative analysis of spiral arteries lined by Prl2c2/Plf-
positive SpA-TGCs and spiral artery diameter, serial transverse
sections of E10.5 conceptuses were prepared and subjected to in situ
hybridization with probes for Prl3d1/Pl1 and Prl2c2/Plf for TGCs, and
Pecam1 for endothelial cells. To provide a reference point for the extent
of trophoblast invasion in different samples, histological sections
just above the layer of P-TGCs surrounding the implantation site, with
minimal Prl3d1/Pl1 staining at the center, were deﬁned as the “0 μm”
starting point for SpA-TGC invasion (Fig. 3A). The number of sections
above that point and their thickness (8 μm) was used to estimate
the depth of invasion. For example, the sections 160 μm farther backFig. 1. Tpbpa-positive lineage ablation is underway by E10.5 and results in embryonic lethali
(DTA/+) and DTA/+;Tpbpa-Cre double transgenic placentas. Note that expression is not str
DTA system is underway at around E10.5. (B)Wholemount view of fetuses (top row) and hist
Tpbpa-Cre double transgenic mice start to die at around E10.5, with some variability in phe
apoptosis as shown by TUNEL staining of the placenta.into the decidua were deﬁned as “160 μm”. The number of spiral
arteries lined by Prl2c2/Plf-positive cells at 0 μm and 160 μm was
counted in 4 different normal (DTA/+) and 5 different DTA/+;Tpbpa-
Cre conceptuses. For measuring spiral artery diameter, the number of
spiral arteries in normal placenta was ﬁrst determined by measuring
number of lumens lined by Prl2c2/Plf-positive cells. The diameters of
spiral arterieswere thendeterminedbymeasuring theminimum lumen
diameter of the ﬁve largest arteries labeled by Pecam1-positive cells
within the central half of the transverse sections. This distinguished the
arteries from the maternal veins which are more peripherally located
(Adamson et al., 2002).
For quantitative analysis of the maternal blood space in the
labyrinth, parafﬁn sections of E10.5 conceptuses were stained with
hematoxylin and eosin. For each conceptus at E10.5, three different
pictures on the labyrinth of the placenta were taken. The maternal
blood space was identiﬁed by the presence of non-nucleatedmaternal
red blood cells within it. The area fraction of maternal blood space
was estimated by ImageJ as the proportion of the total labyrinth area
occupied by maternal blood space.
Results
DTA/+;Tpbpa-Cre double transgenic conceptuses die at mid-gestation
To induce cell type speciﬁc ablation of the Tpbpa-positive
trophoblast lineage, we crossed Tpbpa-Cre transgenics (Simmonsty associated with apoptosis within the placenta. (A) TpbpamRNA expression in control
ikingly reduced until E10.5, indicating Tpbpa-positive lineage ablation by Cre activated
ological sections of placentas stainedwith H&E or TUNEL for cell death. Note thatDTA/+;
notype, which is associated with reduced size as shown by H&E staining and increased
234 D. Hu, J.C. Cross / Developmental Biology 358 (2011) 231–239et al., 2007) with mice carrying a conditionally-activated DTA gene
(Ivanova et al., 2005). This approach allows the conditional expression
of DTA upon Cre-mediated excision of a ﬂoxed region containing
transcriptional termination sequences, resulting in death of ectopla-
cental cone/spongiotrophoblast cells that express Tpbpa-Cre. Charac-
terization of progeny from E9.5 to 12.5 indicated that DTA/+;Tpbpa-
Cre conceptuses started to die by ~E10.5 and none of them survived
beyond E11.5, whereas DTA/+ mice were fully viable (Table 1 and
Fig. 1B). To assess when the cell ablation starts, we examined
placentas for the presence of ectoplacental cone/spongiotrophoblast
cells by expression of the endogenous Tpbpa gene. The number of
Tpbpa-expressing cells was dramatically reduced in the placenta by
~E10.5 (Fig. 1A). This ﬁt with histological assessment of the placentas at
E10.5 which showed that the size of DTA/+;Tpbpa-Cre placentas was
dramatically reduced and was associated with increased apoptosis of
cells as shownbyTUNEL staining (Fig. 1B). Interestingly, TUNEL-positive
cells were observed not only in the spongiotrophoblast but also the
labyrinth layer. Since Tpbpa-positive cells do not contribute to the
labyrinth (Simmons et al., 2007), the latter effect is likely a secondary
consequence. These data indicated that although Tpbpa-Cre starts to
express at least as early as E8.5 (Simmons et al., 2007), cell ablation only
becomes extensive around two days later. Delays in cell death after the
onset of DTA expression havebeen reportedpreviously (Brockschnieder
et al., 2004; Ivanova et al., 2005) and presumably reﬂect that time is
required for the toxin to accumulate and/or that trophoblast cells are
somewhat resistant.Fig. 2. Consequences of trophoblast cell type loss after Tpbpa positive lineage ablation at E10
trophoblast cells (GlyTC). Tpbpa-positive cell ablation results in reduction of spiral artery as
but not parietal TGCs (P-TGCs) as shown by staining of their markers at E10.5. (B) P-TGC
(arbitrary units) is not signiﬁcantly reduced (PN0.05).Trophoblast cell ablations in DTA/+;Tpbpa-Cre conceptuses
To assess the consequences of ablating Tpbpa-positive cells on the
trophoblast cell lineage that is normally derived from these cells, we
characterized the placentas of DTA/+;Tpbpa-Cre and control (DTA/+)
conceptuses using cell subtype speciﬁc markers. Glycogen trophoblast
cells were identiﬁed by labeling of Pcdh12mRNA andwere found to be
reduced in E10.5 conceptuses (Fig. 2A, data not shown). Staining of
SpA-TGCs by Prl2c2/Plf (Proliferin) demonstrated that while SpA-TGCs
were present lining the spiral arteries in control conceptuses, very few
Prl2c2/Plf-positive cells were detected invading into the decidua of
DTA/+;Tpbpa-Cre conceptuses (Fig. 2A). Staining of C-TGCs by Prl2c2/
Plf also showed thatPrl2c2/Plf-positive cellswere far fewer in theDTA/+;
Tpbpa-Cre conceptuses compared to controls (Fig. 2A). In contrast,
staining of P-TGCs by labeling Prl3d1/Pl1 (Placental lactogen 1) was not
signiﬁcantly different (Fig. 2A). Quantitative analysis demonstrated that
Prl3d1/Pl1-positive cell number andsizewas not signiﬁcantly different in
DTA/+;Tpbpa-Cre compared to control conceptuses at E10.5 (Figs. 2B
and C).
Reduction in spiral artery lumen diameter and decreased maternal blood
in the labyrinth
SpA-TGCs are thought to increase maternal blood ﬂow to the
implantation site by invading into the lumen of spiral arteries
(Adamson et al., 2002). Staining of Prl2c2/Plf on transverse section.5. (A) In situ hybridization using marker genes for various TGC subtypes and glycogen
sociated TGC (SpA-TGCs), canal TGCs (C-TGCs) and glycogen trophoblast cells (GlyTCs)
number per section. Note that it is not signiﬁcantly reduced (PN0.05). (C) P-TGC size
235D. Hu, J.C. Cross / Developmental Biology 358 (2011) 231–239of the implantation sites (decidua plus placenta) showed that in E10.5
control conceptuses, there were 5.5±0.65 spiral arteries containing
Prl2c2/Plf-positive SpA-TGCs at the point that the arteries converge at
the P-TGC layer (Fig. 3A). In contrast, only 2.6±0.60 (Pb0.05) spiral
arteries containing SpA-TGCs were detected in DTA/+;Tpbpa-Cre
conceptuses at the corresponding plane of section. In addition,
whereas SpA-TGCs were readily detected in control placentas
160 μm upstream as a result of endovascular invasion, almost no
Prl2c2/Plf-positive cells were detected upstream in the DTA/+;Tpbpa-
Cre placentas. Quantitative analysis also showed that spiral artery
diameter was less than half in DTA/+;Tpbpa-Cre conceptuses
compared to controls (Pb0.05) (Fig. 3B). To assess whether the
reduced spiral artery diameter affected overall maternal blood
delivery into the placenta, we estimated the volume fraction of
maternal blood space (MBS) within the labyrinth by measuring the
proportion of the labyrinth cross-sectional area occupied by maternal
blood spaces and found that it was reduced by ~50% (Fig. 3C).
While our data clearly implicated the Tpbpa-lineage in the normal
dilatation of spiral arteries during pregnancy, uterine natural killerFig. 3. Reduction of SpA-TGCs invasion is associated with reduced dilation of spiral arteries a
number of spiral arteries containing Prl2c2/Plf-positive SpA-TGCs and the depth of their inv
spiral arteries lined by SpA-TGC at E10.5. (B) Spiral artery lumen diameter. Note that it is redu
cross-sectional area that is occupied by maternal blood space (MBS). Yellow dashed line out
conceptuses at E10.5 (Pb0.05).(uNK) cells from the mother are also thought to play a role (Ashkar
and Croy, 2001). TGCs may regulate uNK cell activity resulting from
the production of the prolactin-like protein hormone PLP-A (Ain
et al., 2003). The Prl4a1/Plpa gene is expressed by the P-TGC, SpA-
TGC and C-TGCs in wildtype placentas (Simmons et al., 2008) and
its expression was signiﬁcantly reduced in DTA/+;Tpbpa-Cre
conceptuses (Fig. 4). However, staining of uNK cells with an
antibody against perforin (pore-forming protein) showed that the
number and localization of differentiated uNK cells was not
obviously different (Fig. 4). We also used immunohistochemistry
to assess the expression of interferon-γ, which is produced by uNK
cells and is implicated in spiral artery remodeling (Ashkar et al.,
2000), but found no obvious difference (Fig. 4). These data suggest
that the reduced diameter of spiral arteries is more likely due to
differences in trophoblast cell function directly than to the effects
on uNK cell localization or function. However, due to the nature
of the method we used for detecting interferon-γ, we cannot
preclude the possibility that interferon-γ released from cells might
be different.nd is associated with decreased maternal blood in the labyrinth. (A) Assessment of the
asion upstream in the spiral artery. Tpbpa-positive cell ablation results in reduction of
ced in DTA/+;Tpbpa-Cre conceptuses at E10.5 (Pb0.05). (C) Proportion of the labyrinth
lines the maternal blood space. Note that it is signiﬁcantly reduced in DTA/+;Tpbpa-Cre
Fig. 4. Prl4a1/Plpa expression is reduced in DTA/+;Tpbpa-Cre conceptuses with no change in perforin-positive uNK cells distribution. Tpbpa-positive cell ablation results in reduction
of Prl4a1/Plpa-expressing cells at E10.5. In contrast, that the number and distribution of mature uNK cells was not obviously different as shown by perforin protein staining. The
interferon γ expression in implantation sites by immunohistochemistry staining did not show signiﬁcant changes after Tpbpa-positive cell ablation. The yellow dashed line separates
the decidua and implantation site. Dec, Decidua; Lab, Labyrinth.
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spongiotrophoblast cells
In wildtype placentas, P-TGCs are derived equally from Tpbpa-
positive and Tpbpa-negative precursors (Simmons et al., 2007). The
ﬁnding that P-TGC cell number was not reduced in DTA/+;Tpbpa-Cre
conceptuses at E10.5 (Fig. 2) suggested that some Tpbpa-negative cells
can compensate for the loss of P-TGCs that normally would have been
derived from the Tpbpa-positive lineage. Even before expression of
Tpbpa, ectoplacental cone/spongiotrophoblast cells express Ascl2
(previously named Mash2), which encodes for a basic helix–loop–
helix transcription factor that is essential for spongiotrophoblast layer
maintenance (Tanaka et al., 1997). Using double in situ hybridization
in wildtype placentas, we found that expression of Tpbpa and
Ascl2 only partially overlaps within the spongiotrophoblast and that
Tpbpa-negative/Ascl2-positive cells were readily detected (Fig. 5A).
The number of Tpbpa-negative/Ascl2-positive cells was dramatically
increased within the spongiotrophoblast layer of DTA/+;Tpbpa-Cre
conceptuses (Fig. 5A) compared to controls. Co-staining for themitotic
marker, phospho-histone 3 showed that cell proliferation was
increased within the spongiotrophoblast layer at E10.5 in the DTA/+;
Tpbpa-Cre placentas (Figs. 5B and C). Dual staining also showed that the
DTA/+;Tpbpa-Cre placentas had a signiﬁcantly higher proportion of Ascl2/
phospho-histone H3 double positive cells (Figs. 5B and D).Discussion
Various TGC cell subtypes have been characterized in the placenta
(Simmons et al., 2007). However, the function of these various
subtypes has only been speculated and has never been directly
demonstrated. Here we used a Cre activated DTA transgenic system to
ablate TGC subtypes and glycogen trophoblast cells that are derived
from Tpbpa-positive precursors. We found that Tpbpa-positive cell
lineage is critical for remodeling spiral arteries during pregnancy and
revealed an unexpected role of Tpbpa-negative/Ascl2-positive cells in
being able to compensate for P-TGC cell loss.
Ablation of Tpbpa-positive cells is associated with maternal vascular changes
During rodent pregnancy, the feto-placental unit builds connec-
tions with the mother through remodeling of maternal vasculature.
The process is thought to be coordinated by SpA-TGCs and uNK cells
(Cross et al., 2002). Glycogen trophoblast cells also invade into the
uterus but do so interstitially and only after E12.5 and not in direct
association with the spiral arteries (Adamson et al., 2002). It has been
suggested that MMP-9 expressed by glycogen trophoblast cells may
play a role in the degradation of ECM surrounding the spiral arteries,
therefore contribute to spiral artery dilation and increased maternal
blood ﬂow (Coan et al., 2006). However, glycogen trophoblast cells
Fig. 5. Ascl2-positive/Tpbpa-negative cell number increases within spongiotrophoblast layer with elevated proliferation in DTA/+;Tpbpa-Cremice. (A) Dual color in situ hybridization
for Ascl2 and TpbpamRNA expression. Note that they overlap within the spongiotrophoblast layer and Ascl2-positive/Tpbpa-negative cells increase in spongiotrophoblast layer in the
DTA/+;Tpbpa-Cremice at E10.5. (B) Dual staining for proliferating cells (phospho-histone 3 positive). More Ascl2-positive/phospho-histone 3-positive (Ascl2+/PHH3+) cells rather
than Tpbpa-positive/phospho-histone 3 positive (Tpbpa+/PHH3+) cells are present within spongiotrophoblast layer in DTA/+;Tpbpa-Cre conceptuses. Arrowheads, PHH3+ cells.
(C) Quantitation of proliferating cells within the spongiotrophoblast (SpT) layer. PHH3+ cell number increases signiﬁcantly within the spongiotrophoblast layer in DTA/+;Tpbpa-Cre
mice (Pb0.05). (D) Percentage of Ascl2+ cells within the PHH3+ cell population in SpT layer in DTA/+;Tpbpa-Cre conceptuses increases signiﬁcantly (Pb0.05).
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ourmice have already shown the spiral artery phenotype (E10.5). This
evidence likely excludes the possibility that glycogen trophoblast cells
facilitate spiral artery remodeling and dilation, at least during early
and mid-gestation. C-TGCs line the maternal blood canals that deliver
blood from the spiral arteries into the labyrinth layer of the placenta
(Adamson et al., 2002). Due to their location, C-TGCs do not
immediately regulate spiral artery remodeling, but they are very
likely to inﬂuence delivery of maternal blood into the labyrinth and
loss of C-TGCs in the double transgenic conceptuses may contribute to
reduction of maternal blood delivery. While the role of uNK cells has
been established by examining the phenotype of NK deﬁcient mice
(Ashkar and Croy, 2001), the exact roles of the SpA-TGCs and how
trophoblast cells interact with uNK cells are not known. One of the
hormones produced by TGCs (PLP-A) has been shown to regulate uNK
cell activity in vitro (Muller et al., 1999), though Prl4a1/Plpa-deﬁcientmice do not show obvious uNK cell changes in localization as shown
by perforin staining (Ain et al., 2004).
Though our current transgenic model ablates the entire lineage
derived from Tpbpa-positive precursors, based on the timing of the
phenotype, we believe that the spiral artery remodeling phenotype
reﬂects the function of SpA-TGCs. Our previous work has shown that
all of SpA-TGCs are derived from Tpbpa-positive precursors (Simmons
et al., 2007). Thus, by breeding the Tpbpa-Cre mice with DTA
conditional transgenic mice we were able to delete SpA-TGCs and
examine the effect on pregnancy outcome. We found that the spiral
arteries in the DTA+/Tpbpa-Cre mice were invaded by signiﬁcantly
fewer SpA-TGCs (Prl2c2/Plf positive), and this was associated with
reduced diameters of the spiral arteries. Since SpA-TGCs are the only
trophoblast cell type that is in direct contact with spiral arteries and
the only trophoblast cell subtype that has invaded into the decidua
by E10.5 when we observed the spiral artery phenotype (glycogen
238 D. Hu, J.C. Cross / Developmental Biology 358 (2011) 231–239trophoblast cells are only detected by E12.5) (Adamson et al.,
2002; Simmons et al., 2007), the data strongly suggest that SpA-
TGCs are required for spiral artery remodeling and lumen dilation. The
signiﬁcant reduction of maternal blood volume within the labyrinth
is likely to be a direct consequence of the reduced spiral artery
diameters.
The mechanism by which SpA-TGCs promote the dilation of spiral
arteries is unknown. In humans, it has been argued that the simple act
of trophoblast cell invasion into the spiral arteries replaces the
endothelial and vascular smooth muscle cells leading to vessel
dilation (Helwig and Le Bouteiller, 2007; Kharﬁ et al., 2003). However,
at least in mice where spiral arteries have been studied throughout
their length, the spiral arteries are dilated throughout their length
despite only being invaded in the distal 20–30% (Adamson et al.,
2002). The alternative hypothesis is that SpA-TGCs have paracrine
effects to promote spiral artery remodeling. SpA-TGCs express various
cytokines including PLF, PLF-RP, PLP-A, PLP-E and PLP-F (Simmons
et al., 2008). PLF and PRP are angiogenic and anti-angiogenic factors,
respectively (Jackson et al., 1994). PLP-A has a modulatory effect on
uNK cells, which regulate maternal vasculature remodeling (Ain et al.,
2003; Muller et al., 1999). Thus, SpA-TGCs are very likely to remodel
maternal vasculature through their paracrine effects either directly on
the vessels or indirectly by affecting uNK cell activity. In our Tpbpa-
Cre/DTA model, we found dramatic decrease of PLF and PLP-A
expression by SpA-TGC. We found no obvious change in the number
or localization of differentiated uNK cells but there are no direct in situ
assays for assessing their activity. Production of IFN-γ by uNK cells has
been shown to play an important role in spiral artery remodeling
in the decidua (Ashkar et al., 2000). Staining for IFN-γ expression by
immunohistochemistry did not show a signiﬁcant difference in the
Tpbpa-Cre/DTA placenta. However, we cannot preclude the possibility
that interferon-γ released from cell might be different in the Tpbpa-
Cre/DTA implantation sites. Taken together our results suggest a direct
paracrine role of SpA-TGCs in regulating maternal vasculature
remodeling.
Our studies provide the ﬁrst direct evidence showing the conse-
quences of reduced trophoblast invasion on spiral artery remodeling
and its potential effects on maternal blood delivery into the placenta.
Endovascular cytotrophoblast cell invasion in the human placenta has
been implicated with spiral artery remodeling but the evidence is
indirect and based on the ﬁndings from cases of preeclampsia and
intrauterine growth restriction of impaired trophoblast invasion (Guzin
et al., 2005;Naicker et al., 2003) and increased uterine artery bloodﬂow
resistance (Matijevic and Johnston, 1999). These human data certainly
ﬁt the model but do not establish a causal relationship.
Compensation for the number of P-TGCs after precursor ablation
Surprisingly, unlike other TGCs subtypes that derived from Tpbpa-
positive precursors, the number of P-TGCs did not signiﬁcantly change
after cell ablation at E10.5. In wildtype placentas, ~50% of P-TGCs are
normally derived from Tpbpa-negative precursors (Simmons et al.,
2007), and so it is likely that these precursors compensate for the loss
of TGCs derived from the Tpbpa-positive cells. This implies that other
cells somehow sense the number of P-TGCs and can adapt if the
number is reduced. A plausible explanation is suggested by the ﬁnding
that P-TGCs express the growth factor Activin, which has paracrine
effects to suppress further TGC differentiation (Natale et al., 2009). To
understand what might be the source of Tpbpa-negative cells, we
carefully examined the expression of Ascl2, which is expressed in and
required for maintenance of spongiotrophoblast and suppression of
excess P-TGC differentiation (Tanaka et al., 1997), and found that
Tpbpa-negative/Ascl2-positive cells are readily detected in the placen-
ta and that their proliferation was increased following Tpbpa-positive
cell ablation. Collectively, the data suggest several key points
concerning the cell populationsmarkedby Ascl2 and Tpbpa expression.First, Tpbpa-positive cells likely originate from cells that are initially
Ascl2-positive, but then become only Tpbpa positive. Second, there
are Ascl2-positive/Tpbpa-negative cells within spongiotrophoblast
layer which became dramatically increased in the DTA/+;Tpbpa-Cre
conceptuses and these cells are the progenitors that compensate
for the number of P-TGCs. The data further suggest that increased
cell proliferation of Ascl2-positive/Tpbpa-negative cells within the
spongiotrophoblast layer serves as a key mechanism for P-TGCs
compensation.
In summary, conditional ablation of Tpbpa-positive cells allowedus
to delete speciﬁc trophoblast cell types and to characterize the effect
on pregnancyoutcome.Humanpreeclampsia has been associatedwith
the failure of extravillous trophoblast cell invasion into spiral arteries
and disturbance of maternal vasculature remodeling. In our mouse
model, we believe that the loss of SpA-TGCs resulted in spiral arteries
without TGCs invasion and signiﬁcant smaller lumen. Further
study of this model will permit us to understand the mechanisms by
which endovascular invading trophoblast cells affect spiral artery
remodeling. It should be stated that a limitation of the current model,
however, is that multiple cell types are impacted by ablation of Tpbpa-
positive precursors. A second and equally important ﬁnding from the
current studies is that, at least with respect to P-TGC numbers, the
placenta shows developmental plasticity such that normal number of
cells can be achieved even if one type of precursor is ablated early in
development.
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